Evolución y salud: evolución experimental y epidemiología
EVOSALUD
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (11)
2023
-
Nanostructured biohybrid material with wide-ranging antiviral action
Nano Research, Vol. 16, Núm. 8, pp. 11455-11463
2022
-
The International Virus Bioinformatics Meeting 2022
Viruses, Vol. 14, Núm. 5
2021
-
Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 113, Núm. 12, pp. 825-832
-
Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak
mSphere, Vol. 6, Núm. 4, pp. e0038921
-
Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection
The Journal of infectious diseases, Vol. 224, Núm. 5, pp. 788-792
2020
-
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure
Antiviral Research, Vol. 174
2017
-
Phylogenetic analysis of an epidemic outbreak of acute hepatitis C in HIV-infected patients by ultra-deep pyrosequencing
Journal of Clinical Virology, Vol. 92, pp. 42-47
2014
-
Computational models of liver fibrosis progression for hepatitis C virus chronic infection
BMC Bioinformatics, Vol. 15
2013
-
Evolutionary dynamics of the E1-E2 viral populations during combination therapy in non-responder patients chronically infected with hepatitis C virus subtype 1b
Infection, Genetics and Evolution, Vol. 13, Núm. 1, pp. 1-10
2011
-
Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain
Journal of Medical Virology, Vol. 83, Núm. 5, pp. 820-826